These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 18408762)

  • 21. Identification of a mitochondrial-binding site on the N-terminal end of hexokinase II.
    Bryan N; Raisch KP
    Biosci Rep; 2015 Apr; 35(3):. PubMed ID: 26182367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hexokinase inhibits flux of fluorescently labeled ATP through mitochondrial outer membrane porin.
    Perevoshchikova IV; Zorov SD; Kotova EA; Zorov DB; Antonenko YN
    FEBS Lett; 2010 Jun; 584(11):2397-402. PubMed ID: 20412805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VDAC, a multi-functional mitochondrial protein as a pharmacological target.
    Shoshan-Barmatz V; Ben-Hail D
    Mitochondrion; 2012 Jan; 12(1):24-34. PubMed ID: 21530686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Voltage dependent anion channels (VDACs): a brief introduction with a focus on the outer mitochondrial compartment's roles together with hexokinase-2 in the "Warburg effect" in cancer.
    Pedersen PL
    J Bioenerg Biomembr; 2008 Jun; 40(3):123-6. PubMed ID: 18780167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ATP produced by oxidative phosphorylation is channeled toward hexokinase bound to mitochondrial porin (VDAC) in beetroots (Beta vulgaris).
    Alcántar-Aguirre FC; Chagolla A; Tiessen A; Délano JP; González de la Vara LE
    Planta; 2013 Jun; 237(6):1571-83. PubMed ID: 23503782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homophilic anchorage of brain-hexokinase to mitochondria-porins revealed by specific-peptide antibody cross recognition.
    Oudard S; Miccoli L; Beurdeley-Thomas A; Dutrillaux B; Poupon MF
    Bull Cancer; 2004 Jun; 91(6):E184-200. PubMed ID: 15562563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondria-mediated ATP depletion by anti-cancer agents of the jasmonate family.
    Goldin N; Heyfets A; Reischer D; Flescher E
    J Bioenerg Biomembr; 2007 Feb; 39(1):51-7. PubMed ID: 17549642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase.
    Gottlob K; Majewski N; Kennedy S; Kandel E; Robey RB; Hay N
    Genes Dev; 2001 Jun; 15(11):1406-18. PubMed ID: 11390360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial VDAC and hexokinase together modulate plant programmed cell death.
    Godbole A; Dubey AK; Reddy PS; Udayakumar M; Mathew MK
    Protoplasma; 2013 Aug; 250(4):875-84. PubMed ID: 23247919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methyljasmonate displays in vitro and in vivo activity against multiple myeloma cells.
    Klippel S; Jakubikova J; Delmore J; Ooi M; McMillin D; Kastritis E; Laubach J; Richardson PG; Anderson KC; Mitsiades CS
    Br J Haematol; 2012 Nov; 159(3):340-51. PubMed ID: 22970818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hexokinase II detachment from the mitochondria potentiates cisplatin induced cytotoxicity through a caspase-2 dependent mechanism.
    Shulga N; Wilson-Smith R; Pastorino JG
    Cell Cycle; 2009 Oct; 8(20):3355-64. PubMed ID: 19770592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hexokinase II: the integration of energy metabolism and control of apoptosis.
    Pastorino JG; Hoek JB
    Curr Med Chem; 2003 Aug; 10(16):1535-51. PubMed ID: 12871125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hexokinase 1 blocks apoptotic signals at the mitochondria.
    Schindler A; Foley E
    Cell Signal; 2013 Dec; 25(12):2685-92. PubMed ID: 24018046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methyl jasmonate induces cell death with mixed characteristics of apoptosis and necrosis in cervical cancer cells.
    Kniazhanski T; Jackman A; Heyfets A; Gonen P; Flescher E; Sherman L
    Cancer Lett; 2008 Nov; 271(1):34-46. PubMed ID: 18599197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mild Alkalization Acutely Triggers the Warburg Effect by Enhancing Hexokinase Activity via Voltage-Dependent Anion Channel Binding.
    Quach CH; Jung KH; Lee JH; Park JW; Moon SH; Cho YS; Choe YS; Lee KH
    PLoS One; 2016; 11(8):e0159529. PubMed ID: 27479079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of 2D BN/SDS-PAGE coupled with mass spectrometry for identification of VDAC-associated protein complexes related to mitochondrial binding sites for type I brain hexokinase.
    Crepaldi CR; Vitale PA; Tesch AC; Laure HJ; Rosa JC; de Cerqueira César M
    Mitochondrion; 2013 Nov; 13(6):823-30. PubMed ID: 23719229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The anti-cancer activities of jasmonates.
    Raviv Z; Cohen S; Reischer-Pelech D
    Cancer Chemother Pharmacol; 2013 Feb; 71(2):275-85. PubMed ID: 23196641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methyl jasmonate induces cell death and loss of hydrogenosomal membrane potential in Trichomonas vaginalis.
    Vilela R; Menna-Barreto RF; Benchimol M
    Parasitol Int; 2010 Sep; 59(3):387-93. PubMed ID: 20483382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural jasmonates of different structures suppress the growth of human neuroblastoma cell line SH-SY5Y and its mechanisms.
    Tong QS; Jiang GS; Zheng LD; Tang ST; Cai JB; Liu Y; Zeng FQ; Dong JH
    Acta Pharmacol Sin; 2008 Jul; 29(7):861-9. PubMed ID: 18565287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting VDAC-bound hexokinase II: a promising approach for concomitant anti-cancer therapy.
    Krasnov GS; Dmitriev AA; Lakunina VA; Kirpiy AA; Kudryavtseva AV
    Expert Opin Ther Targets; 2013 Oct; 17(10):1221-33. PubMed ID: 23984984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.